|
1
|
Boras-Granic K and Hamel PA:
Wnt-signalling in the embryonic mammary gland. J Mammary Gland Biol
Neoplasia. 18:155–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: Diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pohl SG, Brook N, Agostino M, Arfuso F,
Kumar AP and Dharmarajan A: Wnt signaling in triple-negative breast
cancer. Oncogenesis. 6:e3102017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morgan RG, Ridsdale J, Tonks A and Darley
RL: Factors affecting the nuclear localization of β-catenin in
normal and malignant tissue. J Cell Biochem. 115:1351–1361. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
MacDonald BT and He X: Frizzled and LRP5/6
receptors for Wnt/β-catenin signaling. Cold Spring Harb Perspect
Biol. 4:a0078802012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu G, Huang H, Garcia Abreu J and He X:
Inhibition of GSK3 phosphorylation of beta-catenin via
phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS One.
4:e49262009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeng X, Tamai K, Doble B, Li S, Huang H,
Habas R, Okamura H, Woodgett J and He X: A dual-kinase mechanism
for Wnt co-receptor phosphorylation and activation. Nature.
438:873–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akinboye ES, Rosen MD, Denmeade SR,
Kwabi-Addo B and Bakare O: Design, synthesis, and evaluation of
pH-dependent hydrolyzable emetine analogues as treatment for
prostate cancer. J Med Chem. 55:7450–7459. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grollman AP: Inhibitors of protein
biosynthesis. V. Effects of emetine on protein and nucleic acid
biosynthesis in HeLa cells. J Biol Chem. 243:4089–4094.
1968.PubMed/NCBI
|
|
12
|
Lambert AC: The treatment of amoebic
dysentery with emetine and bismuth iodide. Br Med J. 1:116–118.
1918. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kane RC, Cohen MH, Broder LE, Bull MI,
Creaven PJ and Fossieck BE Jr: Phase I–II evaluation of emetine
(NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.
Cancer Chemother Rep. 59:1171–1172. 1975.PubMed/NCBI
|
|
14
|
Mastrangelo MJ, Grage TB, Bellet RE and
Weiss AJ: A phase I study of emetine hydrochloride (NSC 33669) in
solid tumors. Cancer. 31:1170–1175. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Panettiere F and Coltman CA Jr: Experience
with emetine hydrochloride (NSC 33669) as an antitumor agent.
Cancer. 27:835–841. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siddiqui S, Firat D and Olshin S: Phase II
study of emetine (NSC-33669) in the treatment of solid tumors.
Cancer Chemother Rep. 57:423–428. 1973.PubMed/NCBI
|
|
17
|
Akinboye ES, Bamji ZD, Kwabi-Addo B, Ejeh
D, Copeland RL, Denmeade SR and Bakare O: Design, synthesis and
cytotoxicity studies of dithiocarbamate ester derivatives of
emetine in prostate cancer cell lines. Bioorg Med Chem.
23:5839–5845. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Akinboye ES, Rosen MD, Bakare O and
Denmeade SR: Anticancer activities of emetine prodrugs that are
proteolytically activated by the prostate specific antigen (PSA)
and evaluation of in vivo toxicity of emetine derivatives. Bioorg
Med Chem. 25:6707–6717. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bicknell GR, Snowden RT and Cohen GM:
Formation of high molecular mass DNA fragments is a marker of
apoptosis in the human leukaemic cell line, U937. J Cell Sci.
107:2483–2489. 1994.PubMed/NCBI
|
|
20
|
Moller M, Weiss J and Wink M: Reduction of
cytotoxicity of the alkaloid emetine through P-glycoprotein
(MDR1/ABCB1) in human Caco-2 cells and leukemia cell lines. Planta
Μed. 72:1121–1126. 2006.
|
|
21
|
Moller M and Wink M: Characteristics of
apoptosis induction by the alkaloid emetine in human tumour cell
lines. Planta Μed. 73:1389–1396. 2007.
|
|
22
|
Rosenkranz V and Wink M: Alkaloids induce
programmed cell death in bloodstream forms of trypanosomes
(Trypanosoma b. brucei). Molecules. 13:2462–2473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Watanabe N, Iwamoto T, Dickinson DA, Iles
KE and Forman HJ: Activation of the mitochondrial caspase cascade
in the absence of protein synthesis does not require c-Jun
N-terminal kinase. Arch Biochem Biophys. 405:231–240. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kong HS, Lee S, Beebe K, Scroggins B,
Gupta G, Lee MJ, Jung YJ, Trepel J and Neckers L: Emetine promotes
von Hippel-Lindau-independent degradation of hypoxia-inducible
factor-2α in clear cell renal carcinoma. Mol Pharmacol.
78:1072–1078. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Foreman KE, Jesse JN III, Kuo PC and Gupta
GN: Emetine dihydrochloride: A novel therapy for bladder cancer. J
Urol. 191:502–509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Q, Yogosawa S, Iizumi Y, Sakai T and
Sowa Y: The alkaloid emetine sensitizes ovarian carcinoma cells to
cisplatin through downregulation of bcl-xL. Int J Oncol.
46:389–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Visnyei K, Onodera H, Damoiseaux R,
Saigusa K, Petrosyan S, De Vries D, Ferrari D, Saxe J, Panosyan EH,
Masterman-Smith M, et al: A molecular screening approach to
identify and characterize inhibitors of glioblastoma stem cells.
Mol Cancer Ther. 10:1818–1828. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mayank and Jaitak V: Molecular docking
study of natural alkaloids as multi-targeted hedgehog pathway
inhibitors in cancer stem cell therapy. Comput Biol Chem.
62:145–154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu D, Choi MY, Yu J, Castro JE, Kipps TJ
and Carson DA: Salinomycin inhibits Wnt signaling and selectively
induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl
Acad Sci USA. 108:13253–13257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M,
Leoni LM, Kipps TJ, Corr M and Carson DA: Activation of the Wnt
signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad
Sci USA. 101:3118–3123. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mandal CC and Ghosh-Choudhury N, Yoneda T,
Choudhury GG and Ghosh-Choudhury N: Simvastatin prevents skeletal
metastasis of breast cancer by an antagonistic interplay between
p53 and CD44. J Biol Chem. 286:11314–11327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vlckova L, Vondrejs V and Necasek J: The
interaction of emetine with DNA and its effect on the adsorption of
certain bacteriophages. Folia Microbiol. (Praha). 15:76–81.
1970.
|
|
33
|
Aoki T, Shimada K, Sakamoto A, Sugimoto K,
Morishita T, Kojima Y, Shimada S, Kato S, Iriyama C, Kuno S, et al:
Emetine elicits apoptosis of intractable B-cell lymphoma cells with
MYC rearrangement through inhibition of glycolytic metabolism.
Oncotarget. 8:13085–13098. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou YD, Kim YP, Mohammed KA, Jones DK,
Muhammad I, Dunbar DC and Nagle DG: Terpenoid
tetrahydroisoquinoline alkaloids emetine, klugine, and
isocephaeline inhibit the activation of hypoxia-inducible factor-1
in breast tumor cells. J Nat Prod. 68:947–950. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Milovanovic T, Planutis K, Nguyen A, Marsh
JL, Lin F, Hope C and Holcombe RF: Expression of Wnt genes and
frizzled 1 and 2 receptors in normal breast epithelium and
infiltrating breast carcinoma. Int J Oncol. 25:1337–1342.
2004.PubMed/NCBI
|
|
36
|
Benhaj K, Akcali KC and Ozturk M:
Redundant expression of canonical Wnt ligands in human breast
cancer cell lines. Oncol Rep. 15:701–707. 2006.PubMed/NCBI
|
|
37
|
King TD, Suto MJ and Li Y: The
Wnt/β-catenin signaling pathway: A potential therapeutic target in
the treatment of triple negative breast cancer. J Cell Biochem.
113:13–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nagahata T, Shimada T, Harada A, Nagai H,
Onda M, Yokoyama S, Shiba T, Jin E, Kawanami O and Emi M:
Amplification, up-regulation and over-expression of DVL-1, the
human counterpart of the Drosophila disheveled gene, in primary
breast cancers. Cancer Sci. 94:515–518. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schlange T, Matsuda Y, Lienhard S, Huber A
and Hynes NE: Autocrine WNT signaling contributes to breast cancer
cell proliferation via the canonical WNT pathway and EGFR
transactivation. Breast Cancer Res. 9:R632007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dawood S, Austin L and Cristofanilli M:
Cancer stem cells: Implications for cancer therapy. Oncology
(Williston Park). 28:1101–1107, 1110. 2014.PubMed/NCBI
|
|
41
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Horst D, Kriegl L, Engel J, Jung A and
Kirchner T: CD133 and nuclear beta-catenin: The marker combination
to detect high risk cases of low stage colorectal cancer. Eur J
Cancer. 45:2034–2040. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ibrahim EE, Babaei-Jadidi R, Saadeddin A,
Spencer-Dene B, Hossaini S, Abuzinadah M, Li N, Fadhil W, Ilyas M,
Bonnet D and Nateri AS: Embryonic NANOG activity defines colorectal
cancer stem cells and modulates through AP1- and TCF-dependent
mechanisms. Stem Cells. 30:2076–2087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Iv Santaliz-Ruiz LE, Xie X, Old M, Teknos
TN and Pan Q: Emerging role of nanog in tumorigenesis and cancer
stem cells. Int J Cancer. 135:2741–2748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Uzor PF: Recent developments on potential
new applications of emetine as anti-cancer agent. EXCLI J.
15:323–328. 2016.PubMed/NCBI
|
|
46
|
Bamji ZD, Washington KN, Akinboye E,
Bakare O, Kanaan YM and Copeland RL Jr: Apoptotic effects of novel
dithiocarbamate analogs of emetine in prostate cancer cell lines.
Anticancer Res. 35:4723–4732. 2015.PubMed/NCBI
|
